IL17A and psoriasis: Previous studies have shown that quercetin and luteolin could inhibit the activation of the NF-κB pathway, reduce the levels of serum inflammatory factors such as TNF-α, IL-6, and IL-17, and significantly reduce the PASI score of IMQ-induced psoriasis mouse models [29–31].